All News

Individuals who had preoperative percutaneous transthoracic needle biopsy (PTNB) had an increased risk of local-regional recurrence in non–small cell lung cancer (NSCLC).

ACOs serving patients with complex needs are on the rise, but policy changes are needed to support providers treating special populations.

Payer contracts should incentivize the delivery of comprehensive, total-person cancer care, says Brian Mulherin, MD.

CVS Pharmacy acquires stores and prescription files from over 600 Rite Aid and Bartell Drugs pharmacies.

Vivek Subbiah, MD, highlights key topics at the 50th European Society for Medical Oncology (ESMO) Congress, including the rise of tumor-agnostic therapies and the use of artificial intelligence (AI) in cancer care.

Arthritis care remains fragmented and costly, with access disparities prompting calls for preventive strategies, community resources, and systemic improvements.

The number of Black, Hispanic, and Latino students admitted into medical schools fell as rates increased for White and Asian students.

Research highlights the need for diverse data on drug efficacy in atopic dermatitis to address barriers to treatment for patients with skin of color, notes Elain Siegfried, MD.

Eliot F. Battle, MD, discusses how to effectively and successfully treat skin of color.

Approaching homelessness through prevention and local government policies is the next step in addressing increased incidence of homelessness, said Katherine Koh, MD, MSc.

The new indication allows doctors to use upadacitinib before tumor necrosis factor–blocking agents when those treatments are clinically inadvisable.

Opioids were more likely to be prescribed to Medicare beneficiaries living with HIV, which led to opioid use disorder (OUD).

A recent study reveals significant barriers to GLP-1 RA access for diabetes and obesity patients, highlighting racial disparities and high costs.

A new drug application for Dasynoc, a lower-dose, bioequivalent formulation of dasatinib, was not approved for patients with chronic myeloid leukemia and acute lymphoblastic leukemia.

Despite systemic challenges, oncology practices use value-based care, community partnerships, and clinical trials to improve patient access and outcomes, says Brian Mulherin, MD.

WHO's latest report shows alarming trends in antimicrobial resistance, highlighting urgent global challenges and the need to improve surveillance and treatment.

Eliot F. Battle, MD, discusses the art of using lasers and energy-based technology to treat patients with skin of color.

A Mendelian randomization study suggests Actinomyces plays a role in idiopathic pulmonary fibrosis, mediated by circulating inflammatory proteins.

Kelley L. Julian, PharmD, BCOP, discusses optimizing myeloma care, addressing barriers in access to intravenous immunoglobulin and innovative therapies at Huntsman Cancer Institute.

An innovative artificial intelligence (AI) tool enhanced alopecia areata assessment and improved treatment adherence.

A 12-year study in China finds that individuals who dine out often face a higher risk of colon and rectal cancers, with obesity playing a mediating role.

Experts at the Skin of Color Update highlighted the potential benefits of GLP-1 RAs in managing obesity, as well as psoriasis and hidradenitis suppurativa symptom management.

Allergen immunotherapy was associated with reduced medication use and improved asthma control for up to 9 years.

Arthritis is not one disease, and it has an impact that extends far beyond the well-known osteoarthritis or rheumatoid arthritis.

Online racial discrimination, bias, and trauma are linked to anxiety and depression in Black adolescents.

AstraZeneca has struck a deal with the Trump administration to sell lower-priced drugs via TrumpRx, following a similar agreement with Pfizer.

Making sure that colored contact lenses are legitimate before Halloween can prevent eye infection.

Raj Chovatiya, MD, PhD, MSCI, describes how delgocitinib offers a long-term solution for chronic hand eczema, transforming treatment beyond traditional corticosteroids.